Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gentamicin dosage in children

M Taylor, C Keane

    Archives of Disease in Childhood
    |May 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Gentamicin dosing in children requires careful consideration. Doses of 1.7 mg/kg or less were inadequate; 2.5 mg/kg 8-hourly is suggested, with serum monitoring essential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same author

    Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023
    Same author

    Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

    Physical review letters·2022
    Same author

    EEG biomarkers of free recall.

    NeuroImage·2021
    Same author

    EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

    Blood·2020
    Same author

    Novel chyme reinfusion device for gastrointestinal fistulas and stomas: feasibility study.

    The British journal of surgery·2020
    Same journal

    Protecting adolescent confidentiality in the digital age: a global call for adolescent-informed electronic health records.

    Archives of disease in childhood·2026
    Same journal

    Diagnostic accuracy study assessing the ability of paediatric asthma scores to predict admission following initial emergency department bronchodilator therapy: a Clinical Asthma Scoring systems in Paediatric Emergency (CASPER) study.

    Archives of disease in childhood·2026
    Same journal

    Artificial intelligence for child health: current capabilities and the next frontier.

    Archives of disease in childhood·2026
    Same journal

    Troubled origins and lasting impact of the first insulin injection.

    Archives of disease in childhood·2026
    Same journal

    Paediatric readiness assessment tools in emergency care: a scoping review.

    Archives of disease in childhood·2026
    Same journal

    Building a paediatric workforce to deliver the NHS prevention agenda: time for paediatric public health medicine?

    Archives of disease in childhood·2026
    See all related articles

    Area of Science:

    • Pediatric Pharmacology
    • Infectious Diseases
    • Clinical Pharmacy

    Background:

    • Gentamicin is a critical antibiotic for treating serious pediatric infections.
    • Optimizing gentamicin dosage in children is essential to ensure efficacy and minimize toxicity.
    • Pediatric pharmacokinetics of gentamicin can vary significantly with age and clinical status.

    Purpose of the Study:

    • To evaluate the adequacy of serum gentamicin concentrations based on varying intramuscular doses in pediatric patients.
    • To establish evidence-based gentamicin dosing guidelines for children.
    • To highlight the importance of therapeutic drug monitoring for gentamicin therapy.

    Main Methods:

    • Serum gentamicin levels were measured in 49 children aged 2 weeks to 11 years.

    Related Experiment Videos

  • Patients received 8-hourly intramuscular gentamicin doses ranging from 0.7 mg/kg to 4.9 mg/kg.
  • Correlation between administered dose and achieved serum gentamicin concentration was analyzed.

    • Main Results:

    • Intramuscular gentamicin doses of 1.7 mg/kg or lower resulted in subtherapeutic serum concentrations.
    • Higher doses were required to achieve adequate gentamicin levels in the pediatric population.
    • Individual variability in serum concentrations necessitates dose adjustments.

    Conclusions:

    • An 8-hourly intramuscular gentamicin dose of 2.5 mg/kg is proposed as a suitable starting point for most children without renal impairment.
    • Therapeutic drug monitoring of serum gentamicin levels is crucial for optimizing treatment and preventing toxicity.
    • Dose adjustments based on measured serum concentrations are necessary for effective gentamicin therapy in children.